Peter T E Wootton
Overview
Explore the profile of Peter T E Wootton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
117
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wootton P, Arora N, Drenos F, Thompson S, Cooper J, Stephens J, et al.
Hum Mol Genet
. 2007 Jun;
16(12):1437-44.
PMID: 17545304
Animal and human studies suggest that both secretory PLA2 (sPLA2)-V and sPLA2-IIA (encoded, respectively, by the neighbouring PLA2G5 and PLA2G2A genes) contribute to atherogenesis. Elevated plasma sPLA2-IIA predicts coronary heart...
2.
Wootton P, Flavell D, Montgomery H, World M, Humphries S, Talmud P
Nutr Metab Cardiovasc Dis
. 2006 Dec;
17(1):24-31.
PMID: 17174223
Lipoprotein-associated PLA2 (Lp-PLA2) hydrolyses the sn-2 position of glycerophospholipids, in particular platelet activating factor (PAF), generating significant amounts of Lyso-PAF which in turn, via a remodelling pathway, can generate arachidonic...
3.
Flavell D, Wootton P, Myerson S, J World M, Pennell D, Humphries S, et al.
J Mol Med (Berl)
. 2006 Jan;
84(2):126-31.
PMID: 16416313
The adult heart relies predominantly on fatty acids (FA) for energy generation, and defects in FA catabolism cause dramatic left ventricular (LV) growth in early age. Since lipoprotein lipase (LPL)...
4.
Wootton P, Drenos F, Cooper J, Thompson S, Stephens J, Hurt-Camejo E, et al.
Hum Mol Genet
. 2005 Dec;
15(2):355-61.
PMID: 16368710
Recent prospective analysis identified secretory phospholipase A(2)-IIa (sPLA(2)IIa) as a coronary artery disease (CAD) risk predictor. This study aimed to examine the relationship between serum levels of sPLA(2)IIa and variation...
5.
Williams A, Dhamrait S, Wootton P, Day S, Hawe E, Payne J, et al.
J Appl Physiol (1985)
. 2003 Nov;
96(3):938-42.
PMID: 14607851
Accumulating evidence suggests that athletic performance is strongly influenced by genetic variation. One such locus of influence is the gene for angiotensin-I converting enzyme (ACE), which exhibits a common variant...
6.
Dhamrait S, Payne J, Li P, Jones A, Toor I, Cooper J, et al.
Eur Heart J
. 2003 Sep;
24(18):1672-80.
PMID: 14499231
Aims: The contribution of kinins to the beneficial effects of angiotensin I converting enzyme (ACE) inhibition in cardiovascular risk reduction remains unclear. The genes for the kinin inducible B1 receptor...
7.
Jones A, Dhamrait S, Payne J, Hawe E, Li P, Toor I, et al.
Hypertension
. 2003 Aug;
42(4):500-6.
PMID: 12925562
Renin-angiotensin systems may mediate cardiovascular disease pathogenesis through a balance of actions of angiotensin II on (potentially proatherogenic) constitutive type 1 (AT1R) and (potentially antiatherogenic) inducible type 2 (AT2R) receptors....